MarginsXMarginsX
Home › Markets › KPHMW

Kiora Pharmaceuticals Inc (KPHMW)

KPHMW is quoted over the counter, not listed on an exchange. Kiora Pharmaceuticals Inc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close
No daily closes stored yet
1-year return
No daily closes stored yet
Market cap
No stored closes, so no market cap
P/E and P/S
No stored closes

Profile

FieldValue
TickerKPHMW, quoted over the counter
SEC CIK0001372514
SEC industry codePharmaceutical Preparations
Business addressEncinitas, CA
Incorporated inDE

Warning signs

Cash runway
8.6 months
$5.6M cash at September 30, 2026
Share count, 1 year
+20.3%
2025-11-05 to 2026-11-10 · +417.9% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"The factors described above have caused management to determine there is substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-12
Cash and burn$5.6M cash; operating cash flow -$1.9M a quarter.Report 2026-09-30
Shares outstanding4,424,387 (2026-11-10); 3,677,935 a year earlier; 7,689,240 three years earlier. 3y figure adjusted for splits (1-for-9 overall).Cover page 2026-11-10
Reverse splits, 3 years1; latest 1-for-9 on 2024-06-11Source 2024-06-11
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-05-18
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorHaskell & White LLP, Irvine, California, United StatesPCAOB Form AP 2026-04-30
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$1.0M-$1.7M-$558K$5.6MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$2.1M-$1.9M$7.1MNo debt tagsNeeds four quarters10-Q 2026-08-07
Q1 2026
2026-03-31
Not filed-$2.4M-$3.2M$11.0MNo debt tagsNeeds four quarters10-Q 2026-05-08
Q4 2025
2025-12-31
$0-$6.5M-$2.2M$8.7MNo debt tags$010-K 2026-03-25
Q3 2025
2025-09-30
$0$27K-$1.3M$5.5MNo debt tags$010-Q 2026-11-12
Q2 2025
2025-06-30
$0-$2.2M-$3.8M$1.0MNo debt tags$010-Q 2025-08-08
Q1 2025
2025-03-31
$0-$2.2M-$2.7M$3.8MNo debt tags$20K10-Q 2025-05-09
Q4 2024
2024-12-31
$0-$4.2M-$2.3M$3.8MNo debt tags$16.0M10-K 2026-03-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-05-28
Latest annual report10-K2026-03-25
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-12
Latest proxyDEF 14A2026-04-30

Source: SEC EDGAR submissions feed, 929 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier